Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hellerup – page 120

1 458 clinical trials in Hellerup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hellerup at a glance
1 458
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 458 trials in Hellerup

Open in trial search

Status epilepticus

Not recruiting

Study on Ganaxolone for Patients with Refractory Status Epilepticus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ganaxolone
  • Sponsor:Marinus Pharmaceuticals Inc.

Rectal cancer

Not recruiting

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Sjaelland

Pancreatic carcinoma+1

Not recruiting

Study on the Safety and Effects of Nivolumab, Ipilimumab, Gemcitabine, and Paclitaxel for Patients with Advanced Pancreatic Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Region Hovedstaden

Neoplasm

Not recruiting

Study on the Safety and Tolerability of Olaparib in Children and Adolescents with Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB

Psychotic disorder

Not recruiting

Study of Cannabidiol and Risperidone for Treatment of Non-Affective Psychosis in Patients with History of Cannabis Use

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Cannabidiol
  • Sponsor:Region Hovedstaden

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Cardiac arrest

Not recruiting

Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Olanzapine
  • Sponsor:Region Hovedstaden

Erectile dysfunction

Not recruiting

Study on the Safety and Effectiveness of LIB-01 for Treating Erectile Dysfunction in Adult Men

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:LIB-01 monohydrate
  • Sponsor:Dicot Pharma AB

Study Comparing Subcutaneous and Intravenous Human Normal Immunoglobulin for New Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Aarhus University Hospital

Hodgkin's disease

Not recruiting

Study on Early Response to Brentuximab Vedotin and Drug Combination for Advanced Hodgkin Lymphoma Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Brentuximab Vedotin
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Cystic fibrosis

Not recruiting

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Elexacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hellerup

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular diseases including studies of new treatments for heart failure, atrial fibrillation, and atherosclerosis.

  • Heart failure treatment optimization
  • Stroke prevention strategies
  • Hypertension management

Current research examines novel therapeutic approaches like colchicine for heart conditions and innovative anticoagulation treatments.

02 Metabolic Disorders

Comprehensive studies addressing obesity and weight management through innovative therapeutic approaches and lifestyle interventions.

  • Weight reduction treatments
  • Diabetes management
  • Metabolic health optimization

Multiple trials are evaluating new medications including CagriSema and dapiglutide for weight management.

03 Respiratory Medicine

Advanced research in respiratory diseases including studies on vaccines and treatments for various pulmonary conditions.

  • Influenza prevention
  • COPD management
  • Pulmonary fibrosis treatments

Investigations include innovative approaches to lung disease treatment and prevention strategies.

04 Dermatological Studies

Clinical research focusing on skin conditions including treatments for psoriasis and atopic dermatitis.

  • Psoriasis therapies
  • Hidradenitis suppurativa treatment
  • Innovative dermatological interventions

Studies evaluate new biological treatments and their effectiveness in chronic skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.